Guess we'll have to wait until this is approved in other countries for a real answer.

Hard to know the price in other countries when it's free, eh?

It's actually not expensive just because. They don't manufacture this stuff in a pill packing plant with an automated machine that just churns this out.

Cell therapy takes blood from a patient and manufacturers with it to make the drug. It's made manually by a team of people for a specific patient. The material costs alone are a quarter of the price in most cases.

Cell therapy ain't cheap.

It's tricky because the money, time and opportunity cost gone into development, testing and the approval process are also priced into this. Plus the fact that this needs to not only break even but make some money plus the fact that this won't be relevant for a huge market I think (not sure how prevalent SCD is). So it's an outrageous price but probably not just plucked out of thin air